| CADL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CADL shares outstanding history going back to 7/27/2021:
Also see: CADL Market Cap History CADL YTD Return |
CADL Shares Outstanding History — Candel Therapeutics Share Count Over Time
As of 5/7/2026 Candel Therapeutics has 73.27 million CADL shares outstanding. Investors often track the CADL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CADL share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 7/27/2021.
| CADL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
CADL Historical Shares Outstanding: +25.44% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| CADL Stock Price Chart |
| About Candel Therapeutics Inc |
| Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Co. has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. We show 21 historical shares outstanding datapoints in our coverage of CADL's shares outstanding history. Understanding the changing numbers of CADL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CADL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CADL by allowing them to research CADL shares outstanding history as well as any other stock in our coverage universe. |
| CADL Current Stock Quote |
Quotes delayed 20 minutes  Free CADL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CADL Share Performance |
| Shares Outstanding Peers |
| Candel Therapeutics (CADL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CAH Shares Outstanding History CALA Shares Outstanding History CALC Shares Outstanding History CANO Shares Outstanding History CAPN Shares Outstanding History CAPR Shares Outstanding History CARA Shares Outstanding History CARM Shares Outstanding History CASI Shares Outstanding History CASM Shares Outstanding History More Healthcare companies » |
CADL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
